Thijssen, Martijn
20  Ergebnisse:
Personensuche X
?
7

Phase 1 study of the pan-HER inhibitor dacomitinib plus the..:

van Geel, Robin M.J.M ; van Brummelen, Emilie M.J ; Eskens, Ferry A.L.M...
van Geel , R M J M , van Brummelen , E M J , Eskens , F A L M , Huijberts , S C F A , de Vos , F Y F L , Lolkema , M P J K , Devriese , L A , Opdam , F L , Marchetti , S , Steeghs , N , Monkhorst , K , Thijssen , B , Rosing , H , Huitema , A D R , Beijnen , J H , Bernards , R & Schellens , J H M 2020 , ' Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer ' , British Journal of Cancer , vol. 122 , no. 8 , pp. 1166-1174 . https://doi.org/10.1038/s41416-020-0776-z.  , 2020
 
?
 
?
9

Health-related quality of life and lived experiences in mal..:

Thijssen, Carlijn ; Dekker, Silvy ; Bons, Lidia...
Thijssen , C , Dekker , S , Bons , L , Gökalp , A , Kauling , M , Bosch , A , Cuypers , J , Utens , L , Kimmenade , R , Takkenberg , H , Roos , LMH , Goossens , E & Hesselink , J 2020 , ' Health-related quality of life and lived experiences in males and females with thoracic aortic disease and their partners ' , Open Heart , vol. 7 , no. 2 , e001419 . https://doi.org/10.1136/openhrt-2020-001419.  , 2020
 
?
11

Loss of ZBTB24 impairs nonhomologous end-joining and class-..:

Helfricht, Angela ; Thijssen, Peter ; Rother, Magdalena...
info:eu-repo/semantics/altIdentifier/doi/10.1084/jem.20191688.  , 2020
 
?
13

Phase 1 study of the pan-HER inhibitor dacomitinib plus the..:

van Geel, Robin M. J. M ; van Brummelen, Emilie M. J ; Eskens, Ferry A. L. M...
van Geel , R M J M , van Brummelen , E M J , Eskens , F A L M , Huijberts , S C F A , de Vos , F Y F L , Lolkema , M P J K , Devriese , L A , Opdam , F L , Marchetti , S , Steeghs , N , Monkhorst , K , Thijssen , B , Rosing , H , Huitema , A D R , Beijnen , J H , Bernards , R & Schellens , J H M 2020 , ' Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer ' , British Journal of Cancer , vol. 122 , no. 8 , pp. 1166-1174 . https://doi.org/10.1038/s41416-020-0776-z.  , 2020
 
1-15